Navigation Links
Acute Ischemic Stroke Market (AIS): Analyzed and 2022 Forecasts in New Research Report at RnRMarketResearch.com
Date:9/20/2013

Dallas, TX (PRWEB) September 20, 2013

Stroke occurs when the blood supply to the brain is blocked or interrupted, either by blood clots or ruptured blood vessels, depriving the brain of oxygen and nutrients, ultimately leading to the death of brain cells. Stroke is a major cause of death, morbidity, and long-term disability.

To forecast the incident and prevalent cases of stroke in the 6MM, Epidemiologists selected studies that used the WHO definition of stroke: “rapidly developing clinical signs of focal disturbance of cerebral function, lasting more than 24 hours or leading to death, with no apparent cause other than that of vascular origin.” This definition excludes cases of transient ischemic attacks (TIAs), which are neurological deficits lasting less than 24 hours. This report also provides the incident cases of AIS segmented by the TOAST (Trial of Org 10172 in Acute Stroke Treatment) criteria subtypes and the proportion of recurrent cases of AIS out of the total cases of AIS (total cases of AIS = incident cases of first-ever AIS + recurrent cases of AIS) in these major markets.

Complete report is available @ http://www.rnrmarketresearch.com/epicast-report-acute-ischemic-stroke-epidemiology-forecast-to-2022-market-report.html.

Epidemiologists forecast that the incident cases of AIS in the 6MM will increase by 20.10% over the next decade, from 1.25 million cases in 2012 to 1.50 million cases in 2022, with more than 50% of the cases being in the US alone. The number of prevalent cases of AIS in the 6MM will increase by 18.6% over the forecast period, from 9.48 million cases in 2012 to 11.24 million cases in 2022. The substantially higher number of prevalent cases of AIS compared with the number of incident cases indicates that a higher proportion of stroke victims survive after the event for longer time periods. However, these stroke survivors will live with serious disabilities, making stroke a major burden for the affected individual and the entire healthcare system in each country.

Scope

  •     The Acute Ischemic Stroke (AIS) EpiCast Report and EpiCast Model provide an overview of the risk factors, comorbidities and the global epidemiological trends for AIS in the six major markets (6MM: US, France, Germany, Italy, Spain, and UK). In addition, this report includes a 10-year epidemiological forecast of the incident cases of AIS (all new cases of a first-ever AIS in a defined population in a specified time period) and the prevalent cases of AIS (all survivors of a first-ever AIS in a defined population at a specified point in time) segmented by sex and age (ages 20–85+ years). This report also provides the incident cases of AIS segmented by the TOAST criteria subtypes and the proportion of recurrent cases of AIS out of the total cases of AIS.
  •     The AIS epidemiology report and model were written and developed by Masters- and PhD-level epidemiologists.
  •     The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 6MM.
  •     The EpiCast Model is easy to navigate, interactive with dashboards, and epidemiology-based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over a 10-year forecast period using reputable sources.

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=116035 .

Reasons to Buy

  •     Develop business strategies by understanding the trends shaping and driving the global AIS market.
  •     Quantify patient populations in the global AIS market to improve product design, pricing, and launch plans.
  •     Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for AIS therapeutics in each of the markets covered.
  •     Identify the percentage of each TOAST subtype among incident cases of AIS.

Related Reports to “Acute Ischemic Stroke” Market see below:

Acute Ischemic Stroke – Pipeline Review, H1 2013
http://www.rnrmarketresearch.com/acute-ischemic-stroke-pipeline-review-h1-2013-market-report.html .

Acute Ischemic Stroke – Pipeline Review, H2 2013
http://www.rnrmarketresearch.com/acute-ischemic-stroke-pipeline-review-h2-2013-market-report.html .

Contact sales(at)rnrmarketresearch(dot)com for further information.

About Us:

RnRMarketResearch.com (http://www.rnrmarketresearch.com/ .) is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/acute-ischemic-stroke/epidemiology-forecast/prweb11144738.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Get ready for the latest innovations in acute cardiac care
2. Anti-inflammatory and anti-thrombogenic effects of atorvastatin in acute ischemic stroke
3. Survey Showing 91% of Addicts Face Post Acute Withdrawal Published by Recovery First, Inc.
4. Hot Line IV: Late-breaking trials on heart failure and acute coronary syndrome
5. Effective Natural Ways to Combat Acute Pain in the Lower Back
6. Acute Myeloid Leukemia Market (AML) – 2017 Opportunity Analysis and Forecast in New Research Report at ReportsnReports.com
7. Study shows cardiac MRI use reduces adverse events for patients with acute chest pain
8. Intermountain Vein Center Announces Groundbreaking Guidelines in Treatment of Acute Ischemic Stroke
9. Queens scientists develop magic bullet nanomedicine for Acute Lung Injury
10. Variations in antibiotic prescribing of acute rhinosinusitis in united states ambulatory settings
11. VisitorsCoverage Announces Availability of Acute Onset of Pre-Existing Conditions Coverage Plans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... Journey: From the Mountains to the Mission Field”: the story of a missionary couple ... From the Mountains to the Mission Field” is the creation of published author, Carole ... and currently teaches a class of ladies at her church, which she has taught ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... Rockville, Maryland (PRWEB) , ... October 12, 2017 ... ... a magnetic drug delivery system that we intend to develop to enable prevention ... regimens can lead to severe hearing loss, especially in pediatric patients. For cisplatin, ...
(Date:10/12/2017)... D.C. (PRWEB) , ... October 12, 2017 , ... Leading ... their peers in Washington, D.C., for the 49th Congress of the International Society ... ., Vice President of the Center for Cancer and Blood Disorders at ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... AVACEN Medical (AVACEN) announced that its CE-Marked ... those with the widespread pain associated with fibromyalgia in ... Essex, England commented, "I had ... no sleep at all, tremendous pain, with every movement ... [the AVACEN 100] enough, how this has and is ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
Breaking Medicine Technology: